Equities

Shenzhen Lifotronic Technology Co Ltd

688389:SHH

Shenzhen Lifotronic Technology Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)13.00
  • Today's Change-3.72 / -22.25%
  • Shares traded3.25m
  • 1 Year change-42.86%
  • Beta1.1660
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments999932809
Total Receivables, Net18010474
Total Inventory144142113
Prepaid expenses231615
Other current assets, total311----
Total current assets1,6561,1941,010
Property, plant & equipment, net481454314
Goodwill, net516652
Intangibles, net9610096
Long term investments23----
Note receivable - long term2.852.18--
Other long term assets------
Total assets2,3311,8211,474
LIABILITIES
Accounts payable997179
Accrued expenses919146
Notes payable/short-term debt2401320.50
Current portion long-term debt/capital leases0.980.613.52
Other current liabilities, total947375
Total current liabilities525368204
Total long term debt2.5000.61
Total debt2441334.64
Deferred income tax--0.22--
Minority interest0.883.682.52
Other liabilities, total6.008.7512
Total liabilities535381219
SHAREHOLDERS EQUITY
Common stock428422422
Additional paid-in capital613490482
Retained earnings (accumulated deficit)756528351
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity1,7971,4401,255
Total liabilities & shareholders' equity2,3311,8211,474
Total common shares outstanding428422422
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.